Practice Applications for Immunotherapy in Advanced CSCC: A Clinical Forum

Program Overview

In this interactive panel of multidisciplinary experts including a dermatologist and two medical oncologists, discuss the rationale for immunotherapy in CSCC, a brief overview of mechanism of action of immunotherapy and impact on side effects as well as safety and efficacy of approved checkpoint inhibitors, and identifying patients who may benefit from immunotherapy.

Credit Expired
CE Credit Expired
Expires: October 27, 2021

Target Audience

This activity is intended for oncology and dermatology clinicians who manage patients with cutaneous squamous cell carcinoma (CSCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Delineate the safety and efficacy of immunotherapeutic agents for cutaneous squamous cell carcinoma (CSCC)
  • Effectively manage immune-mediated adverse reactions associated with the mechanism of action of checkpoint inhibitors
  • Select therapy for individual patients according to current evidence and guidelines, offering clinical trial enrollment where appropriate

Activity Faculty

Chrysalyne D. Schmults, MD, MSCE

Chrysalyne Schmults, MD, MSCE (Chair)

Associate Professor, Dermatology
Harvard Medical School
Director, Mohs and Dermatologic Surgery Center
Vice Chair, Surgical Oncology for the Department of Dermatology
Brigham and Women’s Faulkner Hospital/Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Paolo Bossi, MD

Associate Professor, Medical Oncology
University of Brescia
Brescia, Italy

Axel Hauschild, MD

Professor, Dermatology
Head, Dermato-oncology
Department of Dermatology
University of Kiel
Kiel, Germany

Céleste Lebbe, MD, PhD

Professor, Dermatology
Head of the Oncodermatology Center
Dermatology Department
AP-HP Hôpital Saint Louis
Paris Diderot Université
Paris, France

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

© Copyright 2023. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources